An evaluation of Australian pharmacist's attitudes on expanding their prescribing role

Kreshnik Hoti, Bruce Sunderland, Jeffery Hughes, Richard Parsons

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Objectives To evaluate the views of Australian pharmacists on expanded pharmacist prescribing roles and identify important drivers and barriers to its implementation. Setting Pharmacists in Australia. Method Data were collected using a self-administered questionnaire distributed nationally to a random sample of pharmacists either directly, or in the case of one state, via community pharmacies. One-way ANOVA and ξ 2 testing were used to identify significant associations. Factor analysis was conducted to pool variables and the derived factors were subjected to regression analysis. Main outcome measures Perceptions of Australian pharmacists on expanded prescribing and the relationships between variables derived. Results A total of 2592 questionnaires were distributed and a response rate of 40.4% was achieved (n = 1049). Of the respondents 83.9% strongly agreed/agreed to an expanded prescribing role for pharmacists and 97.1% reported they would need further training. Of the respondents 896 agreed that pharmacists should engage in supplementary, independent prescribing or both. Of these 69.1% preferred only supplementary prescribing, 3.3% independent prescribing and 27.4% both models. Both models were found to be positive predictors of expanding pharmaceutical services through prescribing (P < 0.001) with supplementary prescribing showing a stronger association (β = 0.52 vs. β = 0.18). Pharmacists' opinion based on their current perceptions of their clients was an important predictor in expanding pharmaceutical services through prescribing (P = 0.005). Inadequate training in patient assessment, diagnosis and monitoring were the strongest barriers to expanded pharmacist prescribing (P < 0.001). Conclusions The majority of Australian pharmacists supported an expanded pharmacist prescribing role. Support for supplementary was stronger than independent prescribing. Pharmacists acknowledged that they would need further training to perform such roles.

Original languageEnglish
Pages (from-to)610-621
Number of pages12
JournalPharmacy World and Science
Volume32
Issue number5
DOIs
Publication statusPublished - 1 Oct 2010
Externally publishedYes

Fingerprint

Pharmacists
Factor analysis
Analysis of variance (ANOVA)
Regression analysis
Pharmaceutical Preparations
Monitoring
Testing
Pharmaceutical Services
Pharmacies
Statistical Factor Analysis
Analysis of Variance
Regression Analysis
Outcome Assessment (Health Care)

Cite this

Hoti, Kreshnik ; Sunderland, Bruce ; Hughes, Jeffery ; Parsons, Richard. / An evaluation of Australian pharmacist's attitudes on expanding their prescribing role. In: Pharmacy World and Science. 2010 ; Vol. 32, No. 5. pp. 610-621.
@article{5861587e5bf846e5bca4ce43de489ed7,
title = "An evaluation of Australian pharmacist's attitudes on expanding their prescribing role",
abstract = "Objectives To evaluate the views of Australian pharmacists on expanded pharmacist prescribing roles and identify important drivers and barriers to its implementation. Setting Pharmacists in Australia. Method Data were collected using a self-administered questionnaire distributed nationally to a random sample of pharmacists either directly, or in the case of one state, via community pharmacies. One-way ANOVA and ξ 2 testing were used to identify significant associations. Factor analysis was conducted to pool variables and the derived factors were subjected to regression analysis. Main outcome measures Perceptions of Australian pharmacists on expanded prescribing and the relationships between variables derived. Results A total of 2592 questionnaires were distributed and a response rate of 40.4{\%} was achieved (n = 1049). Of the respondents 83.9{\%} strongly agreed/agreed to an expanded prescribing role for pharmacists and 97.1{\%} reported they would need further training. Of the respondents 896 agreed that pharmacists should engage in supplementary, independent prescribing or both. Of these 69.1{\%} preferred only supplementary prescribing, 3.3{\%} independent prescribing and 27.4{\%} both models. Both models were found to be positive predictors of expanding pharmaceutical services through prescribing (P < 0.001) with supplementary prescribing showing a stronger association (β = 0.52 vs. β = 0.18). Pharmacists' opinion based on their current perceptions of their clients was an important predictor in expanding pharmaceutical services through prescribing (P = 0.005). Inadequate training in patient assessment, diagnosis and monitoring were the strongest barriers to expanded pharmacist prescribing (P < 0.001). Conclusions The majority of Australian pharmacists supported an expanded pharmacist prescribing role. Support for supplementary was stronger than independent prescribing. Pharmacists acknowledged that they would need further training to perform such roles.",
keywords = "Attitudes, Australia, Independent prescribing, Pharmacist prescribing, Pharmacists, Supplementary prescribing",
author = "Kreshnik Hoti and Bruce Sunderland and Jeffery Hughes and Richard Parsons",
year = "2010",
month = "10",
day = "1",
doi = "10.1007/s11096-010-9400-2",
language = "English",
volume = "32",
pages = "610--621",
journal = "International Journal of Clinical Pharmacy",
issn = "0928-1231",
publisher = "Springer",
number = "5",

}

An evaluation of Australian pharmacist's attitudes on expanding their prescribing role. / Hoti, Kreshnik; Sunderland, Bruce; Hughes, Jeffery; Parsons, Richard.

In: Pharmacy World and Science, Vol. 32, No. 5, 01.10.2010, p. 610-621.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - An evaluation of Australian pharmacist's attitudes on expanding their prescribing role

AU - Hoti, Kreshnik

AU - Sunderland, Bruce

AU - Hughes, Jeffery

AU - Parsons, Richard

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Objectives To evaluate the views of Australian pharmacists on expanded pharmacist prescribing roles and identify important drivers and barriers to its implementation. Setting Pharmacists in Australia. Method Data were collected using a self-administered questionnaire distributed nationally to a random sample of pharmacists either directly, or in the case of one state, via community pharmacies. One-way ANOVA and ξ 2 testing were used to identify significant associations. Factor analysis was conducted to pool variables and the derived factors were subjected to regression analysis. Main outcome measures Perceptions of Australian pharmacists on expanded prescribing and the relationships between variables derived. Results A total of 2592 questionnaires were distributed and a response rate of 40.4% was achieved (n = 1049). Of the respondents 83.9% strongly agreed/agreed to an expanded prescribing role for pharmacists and 97.1% reported they would need further training. Of the respondents 896 agreed that pharmacists should engage in supplementary, independent prescribing or both. Of these 69.1% preferred only supplementary prescribing, 3.3% independent prescribing and 27.4% both models. Both models were found to be positive predictors of expanding pharmaceutical services through prescribing (P < 0.001) with supplementary prescribing showing a stronger association (β = 0.52 vs. β = 0.18). Pharmacists' opinion based on their current perceptions of their clients was an important predictor in expanding pharmaceutical services through prescribing (P = 0.005). Inadequate training in patient assessment, diagnosis and monitoring were the strongest barriers to expanded pharmacist prescribing (P < 0.001). Conclusions The majority of Australian pharmacists supported an expanded pharmacist prescribing role. Support for supplementary was stronger than independent prescribing. Pharmacists acknowledged that they would need further training to perform such roles.

AB - Objectives To evaluate the views of Australian pharmacists on expanded pharmacist prescribing roles and identify important drivers and barriers to its implementation. Setting Pharmacists in Australia. Method Data were collected using a self-administered questionnaire distributed nationally to a random sample of pharmacists either directly, or in the case of one state, via community pharmacies. One-way ANOVA and ξ 2 testing were used to identify significant associations. Factor analysis was conducted to pool variables and the derived factors were subjected to regression analysis. Main outcome measures Perceptions of Australian pharmacists on expanded prescribing and the relationships between variables derived. Results A total of 2592 questionnaires were distributed and a response rate of 40.4% was achieved (n = 1049). Of the respondents 83.9% strongly agreed/agreed to an expanded prescribing role for pharmacists and 97.1% reported they would need further training. Of the respondents 896 agreed that pharmacists should engage in supplementary, independent prescribing or both. Of these 69.1% preferred only supplementary prescribing, 3.3% independent prescribing and 27.4% both models. Both models were found to be positive predictors of expanding pharmaceutical services through prescribing (P < 0.001) with supplementary prescribing showing a stronger association (β = 0.52 vs. β = 0.18). Pharmacists' opinion based on their current perceptions of their clients was an important predictor in expanding pharmaceutical services through prescribing (P = 0.005). Inadequate training in patient assessment, diagnosis and monitoring were the strongest barriers to expanded pharmacist prescribing (P < 0.001). Conclusions The majority of Australian pharmacists supported an expanded pharmacist prescribing role. Support for supplementary was stronger than independent prescribing. Pharmacists acknowledged that they would need further training to perform such roles.

KW - Attitudes

KW - Australia

KW - Independent prescribing

KW - Pharmacist prescribing

KW - Pharmacists

KW - Supplementary prescribing

UR - http://www.scopus.com/inward/record.url?scp=78349310061&partnerID=8YFLogxK

U2 - 10.1007/s11096-010-9400-2

DO - 10.1007/s11096-010-9400-2

M3 - Article

VL - 32

SP - 610

EP - 621

JO - International Journal of Clinical Pharmacy

JF - International Journal of Clinical Pharmacy

SN - 0928-1231

IS - 5

ER -